These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9329597

  • 1. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
    Schwarz-Roeger U, Petzoldt B, Waldschmidt R, Walker RP, Bauknecht T, Kiechle M.
    Anticancer Res; 1997; 17(4B):3041-5. PubMed ID: 9329597
    [Abstract] [Full Text] [Related]

  • 2. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
    Walker R, Crebbin V, Stern J, Scudder S, Schwartz P.
    Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
    [Abstract] [Full Text] [Related]

  • 3. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
    Schutter EM, Mijatovic V, Kok A, Van Kamp GJ, Verstraeten R, Verheijen RH.
    Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
    [Abstract] [Full Text] [Related]

  • 4. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, Chambers JT, Nam JH.
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [Abstract] [Full Text] [Related]

  • 5. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
    Plebani M, Navaglia F, Basso D, De Paoli M, Nicoletto MO, Maraglino E, Torre GC.
    Anticancer Res; 1996 Feb; 16(6B):3833-8. PubMed ID: 9042266
    [Abstract] [Full Text] [Related]

  • 6. UGP in urogenital disorders: Egyptian experience.
    el-Ahmady O, Halim AB, Gad M, Walker R.
    Anticancer Res; 1996 Feb; 16(4B):2301-8. PubMed ID: 8694560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
    Rinne K, Shahabi S, Cole L.
    Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
    [Abstract] [Full Text] [Related]

  • 20. Urinary gonadotropin peptide levels in preeclamptic and normotensive pregnant women. Results from a pilot case-control study.
    Williams MA, Luthy DA, Zingheim RW, Zebelman AM, Sorensen TK, Resta RG.
    Gynecol Obstet Invest; 1998 Aug; 45(1):24-8. PubMed ID: 9473159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.